FDA.reportPublic FDA data

Kedbumin 25 % per 50 ML Injection

RxCUI
1742222
RxNorm name
Kedbumin 25 % per 50 ML Injection
Display name
Kedbumin 25 % per 50 ML Injection
Full name
Kedbumin 25 % per 50 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125384KedbuminAlbumin (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
57bd6811-8619-11e0-9d78-0800200c9a66KEDBUMIN 25 % in 50 ML Injection [PSN] · 50 ML albumin human, USP 250 MG/ML Injection [Kedbumin] [SBD] · Kedbumin 12.5 GM per 50 ML Injection [SY] · Kedbumin 25 % per 50 ML Injection [SY]417These highlights do not include all the information needed to use KEDBUMIN ® safely and effectively. See full prescribing information for KEDBUMIN ® [Albumin (Human) U.S.P.] sterile, aqueous solution for single dose intravenous administration Initial U.S. Approval: June, 2011.20250627